Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes.

Oncotarget · 2017 · PMC5421899 · PMID 28212536

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

Consistent with results obtained with the DU145-DR and DU145 cells, there was an overall trend in the difference in survival between PC3-DR cells and PC3 cells after treatment with CBZ.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.